domperidone has been researched along with Hypoglycemia in 2 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The intensity of dopamine (DA) effects on the pituitary around the adenoma was evaluated by measuring thyroid stimulating hormone (TSH) responses to intravenous injection of domperidone (10 mg) a new DA receptor blocking drug that does not penetrate the blood-brain barrier." | 3.66 | Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. ( Cook, DB; Gomez-Pan, A; Hall, R; Lewis, M; McGregor, AM; Rodriguez-Arnao, MD; Scanlon, MF; Weightman, D, 1981) |
| "Hypoglycemia was induced by intravenous insulin injection (0." | 2.70 | Hyperprolactinemia does not influence hypothalamic-pituitary-adrenocortical function during hypoglycemia in women. ( Cervenakova, Z; Imrich, R; Koska, J; Ksinantova, L; Kvetnansky, R; Rovensky, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imrich, R | 1 |
| Rovensky, J | 1 |
| Cervenakova, Z | 1 |
| Ksinantova, L | 1 |
| Kvetnansky, R | 1 |
| Koska, J | 1 |
| Scanlon, MF | 1 |
| Rodriguez-Arnao, MD | 1 |
| McGregor, AM | 1 |
| Weightman, D | 1 |
| Lewis, M | 1 |
| Cook, DB | 1 |
| Gomez-Pan, A | 1 |
| Hall, R | 1 |
1 trial available for domperidone and Hypoglycemia
| Article | Year |
|---|---|
Hyperprolactinemia does not influence hypothalamic-pituitary-adrenocortical function during hypoglycemia in women.
Topics: Adrenal Cortex; Adult; Blood Glucose; Domperidone; Epinephrine; Female; Humans; Hyperprolactinemia; | 2002 |
1 other study available for domperidone and Hypoglycemia
| Article | Year |
|---|---|
Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
Topics: Adenoma; Adolescent; Adult; Benzimidazoles; Domperidone; Female; Growth Hormone; Humans; Hydrocortis | 1981 |